폐쇄수면무호흡증환자에서 자동 비강기도양압기 사용 후 지속되는 주간졸림의 예측인자
Predictable Factors of Residual Sleepiness in Auto-PAP Users With Obstructive Sleep Apnea
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Some patients with obstructive sleep apnea (OSA) remain sleepy despite adequate use of nasal positive airway pressure (PAP). To investigate the clinical and polysomnographic factors related to residual daytime sleepiness in OSA patients with adequate PAP-treatment for more than 3 months. Methods: We enrolled consecutively 101 patients, who were diagnosed with moderate to severe OSA by overnight polysomnography. All of them complained of daytime sleepiness and started using nasal Auto-PAP (APAP). Patients who had used APAP adequately (≥70% of nocturnal sleep time, ≥5 days a week) for more than 3 months were divided into a group with residual excessive sleepiness (RES; Epworth sleepiness scale, ESS ≥10) and a group without RES (Non-RES) (ESS<10). Clinical and polysomnographic variables were compared between two groups. Results: Fifty-six patients (55.4%, 56/101) who had used APAP adequately (mean 9.6 months) were enrolled finally. Twenty (35.7%) had RES (mean ESS: 15.2 decreased to 12.4 after PAP therapy) while 36 had no RES (mean ESS: 13.1→6.0). Hypertension was more frequent in RES patients. Furthermore, RES patients were sleepier than Non-RES ones before APAP treatment started. Other clinical, demographic, polysomnography findings and compliance of APAP were not different between two. On multivariate logistic analysis regression, baseline ESS (odd ratio [OR] 1.34 [1.07-1.67]), history of hyperlipidemia (OR 5.04 [1.14-22.33]) were significantly associated with RES. Conclusions: Our findings showed that 35.7% of OSA patients remained sleepy after an adequate PAP therapy. Predictors of RES were a history of hyperlipidemia and a higher baseline ESS.
Abstract
Background: Some patients with obstructive sleep apnea (OSA) remain sleepy despite adequate use of nasal positive airway pressure (PAP). To investigate the clinical and polysomnographic factors related to residual daytime sleepiness in OSA patients with adequate PAP-treatment for more than 3 months. Methods: We enrolled consecutively 101 patients, who were diagnosed with moderate to severe OSA by overnight polysomnography. All of them complained of daytime sleepiness and started using nasal Auto-PAP (APAP). Patients who had used APAP adequately (≥70% of nocturnal sleep time, ≥5 days a week) for more than 3 months were divided into a group with residual excessive sleepiness (RES; Epworth sleepiness scale, ESS ≥10) and a group without RES (Non-RES) (ESS<10). Clinical and polysomnographic variables were compared between two groups. Results: Fifty-six patients (55.4%, 56/101) who had used APAP adequately (mean 9.6 months) were enrolled finally. Twenty (35.7%) had RES (mean ESS: 15.2 decreased to 12.4 after PAP therapy) while 36 had no RES (mean ESS: 13.1→6.0). Hypertension was more frequent in RES patients. Furthermore, RES patients were sleepier than Non-RES ones before APAP treatment started. Other clinical, demographic, polysomnography findings and compliance of APAP were not different between two. On multivariate logistic analysis regression, baseline ESS (odd ratio [OR] 1.34 [1.07-1.67]), history of hyperlipidemia (OR 5.04 [1.14-22.33]) were significantly associated with RES. Conclusions: Our findings showed that 35.7% of OSA patients remained sleepy after an adequate PAP therapy. Predictors of RES were a history of hyperlipidemia and a higher baseline ESS.
참고문헌 (48)
- Young T, "Epidemiology of obstructive sleep apnea: a population health perspective", Am J Respir Crit Care Med, 165, pp.1217~1239 (2002)
- Collop N., "The effect of obstructive sleep apnea on chronic medical disorders", Cleve Clin J Med, 74, pp.72~78 (2007)
- Ferini-Strambi L, "Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP)", Brain Res Bull, 61, pp.87~92 (2003)
- Ohayon MM., "The effects of breathing-related sleep disorders on mood disturbances in the general population", J Clin Psychiatry, 64, pp.1195~1200 (2003)
- Smolensky MH, "Sleep disorders, medical conditions, and road accident risk", Accid Anal Prev, 43, pp.533~548 (2011)
- Sassani A, "Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome", Sleep, 27, pp.453~458 (2004)
- Noda A, "Daytime sleepiness and automobile accidents in patients with obstructive sleep apnea syndrome", Psychiatry Clin Neurosci, 52, pp.221~222 (1998)
- Rey de Castro J, "Using a generic measure of quality of life in patients with obstructive sleep apnea", Sleep Breath, 15, pp.729~735 (2010)
- Engleman HM, "Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea", hypopnoea syndrome, 2004, pp.59, 618~622
- Weaver TE, "Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning", Sleep, 30, pp.711~719 (2007)
- Marin JM, "Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study", Lancet, 365, pp.1046~1053 (2005)
- Marshall NS, "Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a metaanalysis", Thorax, 61, pp.430~434 (2006)
- Weaver TE, "Adherence to continuous positive airway pressure therapy: the challenge to effective treatment", Proc Am Thorac Soc, 5, pp.173~178 (2008)
- Santamaria J, "Persistent sleepiness in CPAP treated obstructive sleep apnea patients: evaluation and treatment", Sleep Med Rev, 11, pp.195~207 (2007)
- Pepin JL, "Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study", Eur Respir J, 33, pp.1062~1067 (2009)
- Kingshott RN, "Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea", hypopnea syndrome, 2001, pp.163, 918~923
- Sin DD, "Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study", Chest, 121, pp.430~435 (2002)
- Schwartz JR, "Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study", Chest, 124, pp.2192~2199 (2003)
- Guilleminault C, "Tiredness and somnolence despite initial treatment of obstructive sleep apnea syndrome (what to do when an OSAS patient stays hypersomnolent despite treatment)", Sleep, 19, pp.117~122 (1996)
- Bixler EO, "Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression", J Clin Endocrinol Metab, 90, pp.4510~4515 (2005)
- Vernet C, "Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms", Eur Respir J, 38, pp.98~105 (2011)
- Nolan GM, "Auto-adjusting versus fixed positive pressure therapy in mild to moderate obstructive sleep apnoea", Sleep, 30, pp.189~194 (2007)
- American Academy of Sleep Medicine, "The International Classification of sleep disorders, 2nd ed.:Diagnostic and coding manual" (2005), American Academy of Sleep Medicine
- Quan SF, "Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research", Sleep, 22, pp.667~689 (1999)
- Johns MW., "A new method for measuring daytime sleepiness: the Epworth sleepiness scale", Sleep, 14, pp.540~545 (1991)
- Cho YW, "The reliability and validity of the Korean version of the Epworth sleepiness scale", Sleep Breath, 15, pp.377~384 (2011)
- Rhee M, "A standardization study of Beck depression inventory I; Korean version (K-BDI): reliability and factor analysis", Korean J Psychopathol, 4, pp.77~95 (1995)
- Beck AT, "An inventory for measuring depression", Arch Gen Psychiatry, 4, pp.561~571 (1961)
- Kasai T, "Subjective sleepiness among patients with obstructive sleep apnea-hypopnea syndrome who were treated with a continuous positive airway pressure device", Sleep Biol Rhythms, 6, pp.155~162 (2008)
- "2009 Korean time use survey" (2009)[URL]
- Daily routines in 22 countries: Diary evidence of average daily time spent in thirty activities, "Fisher K", ~ (2010)
- Simon-Tuval T, "Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treatment", Sleep, 32, pp.545~552 (2009)
- 은기수, "한국의 일상생활에서 남녀의 수면시간과 관련 요인 탐색", 통계연구, 15(2), pp.82~103 (2010), 통계청
- Stradling JR, "Post-CPAP sleepiness–-a specific syndrome?", J Sleep Res, 16, pp.436~438 (2007)
- 김고은, "A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness", SLEEP, 29, pp.1429~1438, AMER ACAD SLEEP MEDICINE
- Koutsourelakis I, "Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients", Eur Respir J, 34, pp.687~693 (2009)
- Zhu Y, "Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model", J Neurosci, 27, pp.10060~10071 (2007)
- Beebe DW, "Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits", J Sleep Res, 11, pp.1~16 (2002)
- Kapur V, "Underdiagnosis of sleep apnea syndrome in U.S. communities", Sleep Breath, 6, pp.49~54 (2002)
- Lee D, "Excessive daytime sleepiness in patients with obstructive sleep apnea", J Korean Sleep Res Soc, 5, pp.43~48 (2008)
- Oksenberg A, "Positional therapy for obstructive sleep apnea patients: A 6-month follow-up study", Laryngoscope, 116, pp.1995~2000 (2006)
- Lam B, "Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea", Thorax, 62, pp.354~359 (2007)
- Jokic R, "Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnea syndrome", Chest, 115, pp.771~781 (1999)
- Sáanchez AI, "CPAP and behavioral therapies in patients with obstructive sleep apnea: effects on daytime sleepiness, mood, and cognitive function", Sleep Med Rev, 13, pp.223~233 (2009)
- Patel SR, "Continuous positive airway pressure therapy for treating gess in a diverse population with obstructive sleep apnea: results of a meta-analysis", Arch Intern Med, 163, pp.565~571 (2003)
- Pack AI, "Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea", Am J Respir Crit Care Med, 164, pp.1675~1681 (2001)
- Barbée F, "Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial", Ann Intern Med, 134, pp.1015~1023 (2001)
- 마은주, "야간 저산소증과 주관적 주간 졸음증이 폐쇄성 수면 무호흡증 환자의 인지기능 저하에 미치는 영향", 대한신경과학회지, 25(4), pp.482~487 (2007), 대한신경과학회